 |
InterPro: IPR001874 Dehydroquinase, class II
Additional Reading
|
|
Toscano MD, Stewart KA, Coggins JR, Lapthorn AJ, Abell C.
Rational design of new bifunctional inhibitors of type II dehydroquinase.
Org. Biomol. Chem. 3 2005 3102-4
[PubMed: 16106291]
http://dx.doi.org/10.1039/b507156a
|
|
Payne RJ, Riboldi-Tunnicliffe A, Kerbarh O, Abell AD, Lapthorn AJ, Abell C.
Design, synthesis, and structural studies on potent biaryl inhibitors of type II dehydroquinases.
2 2007 1010-3
[PubMed: 17487901]
http://dx.doi.org/10.1002/cmdc.200700062
|
|
Robinson DA, Stewart KA, Price NC, Chalk PA, Coggins JR, Lapthorn AJ.
Crystal structures of Helicobacter pylori type II dehydroquinase inhibitor complexes: new directions for inhibitor design.
J. Med. Chem. 49 2006 1282-90
[PubMed: 16480265]
http://dx.doi.org/10.1021/jm0505361
|
|
Maes D, Gonzalez-Ramirez LA, Lopez-Jaramillo J, Yu B, De Bondt H, Zegers I, Afonina E, Garcia-Ruiz JM, Gulnik S.
Structural study of the type II 3-dehydroquinate dehydratase from Actinobacillus pleuropneumoniae.
Acta Crystallogr. D Biol. Crystallogr. 60 2004 463-71
[PubMed: 14993670]
http://dx.doi.org/10.1107/S090744490302969X
|
|
Frederickson M, Roszak AW, Coggins JR, Lapthorn AJ, Abell C.
(1R,4S,5R)-3-Fluoro-1,4,5-trihydroxy-2-cyclohexene-1-carboxylic acid: the fluoro analogue of the enolate intermediate in the reaction catalyzed by type II dehydroquinases.
Org. Biomol. Chem. 2 2004 1592-6
[PubMed: 15162210]
http://dx.doi.org/10.1039/b404535a
|
|
|
InterPro 24.0
|